There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for patients with stage 3 or 4 kidney cancer, who face high recurrence risk.

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...